AzTrials
AzTrials

CHILDREN BORN VERY PRETERM AT SCHOOL-AGENCT01675726

QUALITY OF LIFE OF CHILDREN BORN VERY PRETERM AT SCHOOL-AGE

A study testing questionary on quality of life in people with CHILDREN BORN VERY PRETERM AT SCHOOL-AGE, run by Assistance Publique Hopitaux De Marseille at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

AIMS The aims were 1) to describe the quality of life (QoL) of a cohort of children born very preterm (<28 weeks of gestation) aged 7 to 9 years; 2) to compare children's QoL to the QoL reported by a French general population of reference. Read more about this study

Who is it for?
Ages 7 to 9 years
Conditions the study is for
CHILDREN BORN VERY PRETERM AT SCHOOL-AGE
What is being tested?
questionary on quality of life
Could I receive a placebo?
No, everyone receives an active treatment
How many people
350 participants
Where
1 siteFrance
Study dates
Jan 2013to Aug 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 9 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Child been born between 01/01/2005 and the inclusive 31/12/2007,
  • Extreme premature born Child before 28 weeks of amenorrhea,
  • Child hospitalized after the birth in a level maternity 3 (been born " inborn " or " outborn ")
  • Not dead Child,
  • Child not presenting a cerebral palsy,
  • Child capable of answering a questionnaire in French language,
  • Child among whom the parents(relatives) or the legal representatives accepted the principle of the participation in this study, and having signed a consent,
  • Child granting to participate in the study.

Who cannot join

  • Child died between the birth and dates her(it) evaluation,
  • Child presenting a cerebral palsy
  • Child among whom the parents(relatives) or the legal representatives refused that their child participates in this study

Trial locations and contacts

1 site in 1 country.

France1 site
  • Assistance Publique Hopitaux de Marseille

    Marseille, 13354

Other trials in France

About this study

AIMS The aims were 1) to describe the quality of life (QoL) of a cohort of children born very preterm (<28 weeks of gestation) aged 7 to 9 years; 2) to compare children's QoL to the QoL reported by a French general population of reference. 3) to determine whether socio-demographic factors, neonatal features and neurocognitive status were impacting their QoL.

METHODS:

Read more
  • Multi-centre study: 6 French level three perinatal care units (Marseille, Montpellier, Nantes, Nîmes, Nice and Rouen).
  • Inclusion criteria: all infants born before 28 weeks of gestation between January 2005 and December 2007, from 7 to 9 years old of age at the time of evaluation.
  • Written agreement to participate: collected from parents.
  • Data collection: reports of children's QoL by children and their parents (using standardized validated questionnaires); clinical information about the children, obtained through a medical examination; children neurocognitive profile.
  • Duration of inclusion: over 24 months.
  • Population: of the six structures, approximately 300 children will be evaluated consistent with the active files of the participating centres and an attrition rate of 30%.

PERSPECTIVES This is one of the first studies to collect self-reported data on quality of life of school-age children (7-9 years) born before 28 weeks of gestation. A better understanding of demographic and clinical determinants of QOL of school-age very preterm children may help clinicians involved in the care of these children in their ethical and medical considerations.

Being tested
questionary on quality of life

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • questionary on quality of lifeOther

Study groups in NCT01675726
Study groupRoleWhat they receive
quality of lifeOtherNot described
Receives: Other: questionary on quality of life

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. data on quality of life of school-age children born prematurely

    Measured: 3 years

Secondary outcomes (1)
  1. better understanding of demographic and clinical determinants of QOL of school-age

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Aug 2012 (estimated)
  2. Study startJan 2013
  3. Primary completionJan 2016
  4. Study completionAug 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
350 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01675726
Sponsor's protocol ID
2012-A00193-40
Other IDs
2012-02
Status last verified
Aug 2017
First submitted
28 Aug 2012
Last updated
30 Aug 2017
Results posted
No
Data monitoring committee
No

Publications

  • Gire C, Resseguier N, Brevaut-Malaty V, Marret S, Cambonie G, Souksi-Medioni I, Muller JB, Garcia P, Berbis J, Tosello B, Auquier P; GPQoL study Group. Quality of life of extremely preterm school-age children without major handicap: a cross-sectional observational study. Arch Dis Child. 2019 Apr;104(4):333-339. doi: 10.1136/archdischild-2018-315046. Epub 2018 Jun 30.

    PubMed 29960997

Questions about this trial

What is this clinical trial studying?

A study testing questionary on quality of life in people with CHILDREN BORN VERY PRETERM AT SCHOOL-AGE, run by Assistance Publique Hopitaux De Marseille at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

data on quality of life of school-age children born prematurely (time frame: 3 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01675726, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Aug 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in